PubMed Health⌕ Search

PubMed · 8839992

Method for assessing cardiac function using magnetic resonance imaging.

Abstract

The authors sought to define a method to use magnetic resonance (MR) to assess cardiac function by obtaining short-axis images of the left ventricle (LV) in humans. Sagittal and axial scout1H MR images were used in the protocol. The long axis of the LV was defined in both planes using the mitral valve and left ventricular apex as references. Based on this double angulation, the acquisition planes were created for a series of parallel short-axis images extending from the base to the apex of the left ventricular cavity. Cardiac images acquired with a fast-field echo technique, six slices with 16-20 phases per RR interval, were analyzed, representing the initial 75-80% of the cardiac cycle. For each slice, the endocardial border of the left ventricular chamber was manually traced. Using Simpson's rule, the total LV volume at a given phase was determined, considering the traced area, thickness, and position in three-dimensional space of each of the six constituent slices. The calculated volumes were plotted against time, and the stroke volume, ejection fraction, and cardiac output were determined. These parameters are clinically significant indices of cardiac function. Accurate and useful estimates of LV function can be obtained using MRI according to this protocol.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S J Soldo, L J Haywood, S L Norris, J R Gober, P M Colletti, M R Terk. Method for assessing cardiac function using magnetic resonance imaging.. https://pubmed.ncbi.nlm.nih.gov/8839992/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study.

BACKGROUND: Serum thyroid hormone concentrations decline transiently during critical illness and after surgical procedures. We investigated prospectively the endocrine and haemodynamic effects of tri-iodothyronine treatment after cardiopulmonary bypass operations in children with congenital cardiac malformations. METHODS: We did a randomised, double-blind, placebo-controlled trial, in which 40 children (median age 0.6 years; range 2 days to 10.4 years) were randomly assigned placebo (saline) or one daily infusion of tri-iodothyronine (2 microg/kg bodyweight on day 1 after surgery and 1 microg/kg bodyweight on subsequent postoperative days up to 12 days after surgery. Before and 2 h, 24 h, and 72 h after the first infusion, plasma concentrations of thyroid hormones were measured by RIA, and systolic cardiac function was evaluated by echocardiography. During the postoperative course intensive-care measures were assessed by use of the therapeutic intervention scoring system. FINDINGS: In all patients, postoperative plasma concentrations of thyrotropin, thyroxine, free thyroxine, tri-iodothyronine were abnormally low and plasma concentrations of reverse tri-iodothyronine were raised. After start of treatment, tri-iodothyronine was significantly higher in patients given tri-iodothyronine than in those receiving placebo, whereas thyrotropin, thyroxine, free thyroxine, and reverse tri-iodothyronine remained similar in the two groups. At discharge, thyroid hormones of all patients were within the normal range, but thyrotropin secretion increased to plasma concentrations higher than those seen before treatment. The mean change of cardiac index was significantly higher in children given tri-iodothyronine (20.4% [SD 19.6] vs 10.0% [15.2]; p=0.004). Systolic cardiac function improved most in patients given tri-iodothyronine after longer cardiopulmonary bypass operations. Overall, patients given tri-iodothyronine had significantly lower mean treatment scores. INTERPRETATION: Treatment of children with tri-iodothyronine after cardiopulmonary bypass operations raises tri-iodothyronine plasma concentrations and improves myocardial function especially in patients with low postoperative cardiac output without adverse events, and without delaying postoperative recovery of thyroid function. Furthermore, tri-iodothyronine reduces the need for postoperative intensive care.

Cardiac Output↗

Pharmacokinetic evaluation of triiodothyronine supplementation in children after modified Fontan procedure.

BACKGROUND: Triiodothyronine (T(3)) supplementation may be a useful adjunct in the management of patients after cardiopulmonary bypass. Limited data are available regarding the use and pharmacokinetics of T(3) in children. The present study was performed to evaluate T(3) pharmacokinetics in a cohort of children undergoing the modified Fontan procedure. METHODS AND RESULTS: A total of 28 patients were enrolled in this randomized, prospective study. The patients were divided into 4 groups: 1 group received a placebo and 3 groups received intravenous T(3) at dosages of 0.4, 0.6, and 0.8 microg/kg, respectively. All 28 patients survived their operative procedures. Two patients developed low cardiac output, and 3 patients had pleural effusions. The median length of hospital stay was 7 days. The mean free T(3) level was 316+/-67 pg/dL after then administration of a placebo. Patients who received T(3) had mean peak free T(3) levels of 972+/-88, 1351+/-299, and 1869+/-281 pg/dL for the dosages of 0.4, 0.6, and 0.8 microg/kg, respectively. The calculated half-life of T(3) was 7 hours. CONCLUSIONS: The half-life of intravenous T(3) in children is approximately one-third of that reported for adults. These results provide a framework for studying the efficacy of T(3) supplementation in children undergoing open-heart surgery.

Cardiac Output↗